Dr. Aadhya Tiwari is a translational cancer scientist specializing in glioblastoma and triple-negative breast cancer (TNBC), with a strong focus on tumor microenvironment, cancer stem cells, and therapeutic resistance. Based in the United States, her work bridges molecular discovery and drug development, advancing biomarker-driven and precision oncology strategies.
Current Position
- Research Scientist, MD Anderson Cancer Center
- Postdoctoral Researcher, MD Anderson Cancer Center.
Education
- PhD in Oncology and Cancer Biology, University of Tübingen
Areas of Specialization
- Glioblastoma and brain tumors
- Triple-negative breast cancer (TNBC)
- Tumor microenvironment and cancer stem cells
- Translational oncology and biomarker discovery
- Drug discovery and target validation
- Precision oncology and resistance mechanisms
Clinical & Research Focus
- Glioblastoma stem cell biology and therapeutic resistance
- REST/YB-1 signaling pathways in cancer progression
- Biomarker discovery and gene expression profiling
- Development of translational and preclinical cancer models
- Mechanisms of oncogenic stress and treatment resistance
Technical Expertise
- CRISPR/Cas9 genome editing
- 3D neurosphere culture systems
- In vivo pharmacology and preclinical models
- ChIP-qPCR and gene regulation studies
- Flow cytometry and confocal imaging
- Behavioral rodent assays
Scientific & Translational Impact
- Led and co-authored multiple peer-reviewed publications in cancer biology and translational oncology
- Contributed to biomarker discovery and mechanism-of-action studies in glioblastoma and TNBC
- Experienced in preclinical study design, pharmacodynamics, and IND-enabling workflows
- Strong integration of laboratory research with clinical relevance and therapeutic strategy development
Academic & Mentorship Activities
- Mentored early-career scientists and trainees
- Teaching assistant in brain tumor research programs
- Active contributor to multidisciplinary research collaborations
Professional Profile
- 10+ years of experience in translational cancer research
- Expertise in bridging basic science and therapeutic development
- Strong collaborator across academic and clinical research environments
All information is sourced from publicly available materials.